Blogs
Po Valley Energy (ASX: PVE) Eyes Multi-Well Future With Fresh Hera Gas Deal
Po Valley Energy (ASX: PVE) signed a new 12-month gas supply deal with Hera Trading and cleared a key regulatory step for its Selva Malvezzi four-well drilling program, backed by record August gas revenue.
QBE Insurance (ASX: QBE) Picks New Australia Pacific CEO as Growth Stalls, Margins Hold
QBE Insurance Group has appointed Jonathan Groves as CEO of its Australia Pacific division, effective November 1, 2026, as the business navigates elevated catastrophe activity and softening commercial pricing.
Nine Entertainment (ASX: NEC): Repositioning Story Meets an All-Time Low
Nine Entertainment (ASX: NEC) shares hit an all-time low despite stronger FY26 earnings from Stan, QMS and digital publishing. Brokers remain split on the outlook, while shares test key channel support, with a bullish RSI divergence hinting a possible near-term reverse.
.webp&w=828&q=75)
Tungsten Mining NL (ASX: TGN): $50M Funding Advances Watershed Toward 2027 Production
Tungsten Mining NL (ASX: TGN) has raised $50 million to advance its Watershed tungsten project, with a reported 65.9% WO₃ concentrate grade and targeted 2027 production, positioning Tungsten’s project for its next stage of development.
Nanoveu (ASX: NVU): 16nm SoC Milestone and US Patent to Redefine Edge AI
While Nanoveu (ASX: NVU) has yet to release performance data from its 16nm ECS-DoT chip, receiving physical silicon from TSMC validates the design and moves the platform closer to benchmarking, partner evaluation, and potential commercialisation.
Adavale Resources (ASX: ADD): The 20-Month Build of Its Parkes Gold Inventory
Adavale Resources (ASX:ADD) has boosted its Parkes gold inventory to 383,300 ounces, up from zero in under 20 months. London-Victoria grew 228% to 262,700 ounces after Adavale's first independent drilling in 30 years, with satellite deposits and Calarie adding further scale.
IPD Group (ASX: IPG): Data Centre Demand Builds as Shares React Off Support
IPD Group (ASX: IPG) posted record FY26 results, with data centre revenue up 27% amid Australia's AI infrastructure boom. Shares reacted well off support and now approach key resistance near $6.00.
Tribune Resources (ASX: TBR): Strong Gold Production and Significant Upside Potential
Tribune Resources (ASX: TBR) delivered strong 1H FY2026 earnings, supported by higher gold prices and 10,149oz attributable production from its 36.75% EKJV stake. The company retains strong cash generation, fully funded dividends, expanding mine development, and meaningful upside through Star Trek exploration and elevated gold prices.
Nyrada (ASX: NYR) $14M Capital Raise: Fueling the Path to Global Pharma Partnerships
As Nyrada (ASX: NYR) raises $14 million to advance Xolatryp through Phase IIa trials, the funding extends its development runway and could accelerate clinical milestones, potentially positioning the company for future partnerships with global pharmaceutical companies.
Kaoko Metals (ASX: KAO): Ramps Up Namibia Copper Hunt with Second Drill Rig
Kaoko Metals has mobilised a second drill rig at its Chalkos Copper-Silver Project in Namibia, testing Donkey Hill and Otniel simultaneously as it accelerates exploration following a recent $23m capital raise.
Macroeconomic Report for the Week Ending 20 September 2026 – Australian Market Outlook
Global markets were volatile as higher US rates and Saudi pipeline disruption lifted oil costs, strengthened the dollar and pressured risk assets. Australia faces slowing growth, persistent inflation and a cautious ASX, with healthcare resilient while materials, technology and real estate weakened.
4DMedical (ASX: 4DX): Pricing the Future of Lung Imaging
4DMedical is scaling its lung-imaging software portfolio, led by CT:VQ, across hospitals and imaging networks. FY26 scan volumes rose 77% to 344,075, while cash reached A$278m; however, the company remains loss-making as it pursues commercial adoption and revenue growth.
.webp&w=828&q=75)
AdAlta (ASX: 1AD) $120M Deal: Proof of Platform, Not Profit
While AdAlta (ASX: 1AD) is not the recipient of the $120 million deal, this agreement could do wonders for its IRO technology platform by validating it and making future product development through the platform easier and faster.
.webp&w=828&q=75)
Mount Ridley Mines (ASX: MRD): Selectro Process Impresses as Shares Approach Resistance
Mount Ridley Mines (ASX: MRD) achieved a 91.8% scandium recovery breakthrough with its Selectro™ process, using half the reagent dose, at its largest scandium resource. Shares trade in an uptrend, though technicals suggest limited room for an entry at current levels.
Why KTEK Aerosystems (ASX:KTK) 's $200k Defence Deal Is a Huge Opportunity
KTEK Aerosystems (ASX: KTK) secured its first order from a major Israeli defence prime, a modest US$200,000 milestone within a US$994,100 work package. The real opportunity is a potential US$5 million pipeline, contingent on clearing upcoming engineering reviews and further customer orders.
Mithril Silver and Gold (ASX: MTH): Copalquin Resource Growth Meets a Key Chart Test
Mithril Silver and Gold (ASX: MTH) is advancing its Copalquin district in Mexico, where Target 1 now hosts over 600,000 ounces of gold equivalent. Drilling continues across newer targets, while shares remain in a downtrend, needing a strong break above resistance to signal a reversal.
Bubs Australia (ASX: BUB): BUB's Rally Could Be Just Getting Started
Bubs Australia enters FY27 with permanent FDA approval, wider US distribution and strong American revenue growth. The company is expanding retail channels and rebuilding other markets, but higher freight costs, tariffs, negative EBITDA, and working-capital demands keep profitability and execution in focus.
AML3D (ASX: AL3): Submarine Parts Order Lifts Shares Toward a Key Chart Level
AML3D (ASX: AL3) shares jumped after securing a first US Navy submarine parts order from Austal USA, building on record FY26 revenue. Trading above key support, the stock now tests a technical trigger level, with a confirmed breakout above $0.165 needed to signal further upside.
HeraMED (ASX: HMD)'s Lee Health Deal: A Small Contract with a Much Bigger US Ambition
HeraMED (ASX: HMD) launched a US$317,200 commercial deployment of its HeraCARE maternity platform at Lee Health, Florida, following a successful pilot. The deal, integrated with Epic EMR, is scalable and serves as a reference case for expanding US hospital partnerships, Philips channels, and rural healthcare programs.
EchoIQ (ASX: EIQ) Crisis Decoded: Regulatory Setback, Not Financial Collapse
EchoIQ shares plunged 60% after the FDA issued an NSE notice blocking its heart-failure AI product from the US market. Despite panic selling, strong cash reserves, an active second product, and a management options grant suggest this is a regulatory setback, not a financial collapse.
.webp&w=828&q=75)
Titomic (ASX: TTT): US Air Force Contract Win Follows $16.5 Million Capital Raise
Titomic (ASX: TTT) shares rallied after a US$5 million Air Force contract, following a $16.5 million placement. The advanced manufacturer, still loss-making, is progressing a US redomiciliation while shares test key support with a potential trendline breakout ahead.